Publicacions (177) Publicacions de Jose Schneider Fontan

2023

  1. CD44-targeted nanoparticles for co-delivery of docetaxel and an Akt inhibitor against colorectal cancer

    Biomaterials Advances, Vol. 154

  2. Ki67 and E-cadherin Are Independent Predictors of Long-term Survival in Endometrial Carcinoma

    Anticancer Research, Vol. 43, Núm. 2, pp. 683-687

2022

  1. Breast Cancer Stem Cells: A Clinician's View

    Methods in molecular biology (Clifton, N.J.), Vol. 2471, pp. 345-349

  2. In Vivo Effects of Conditioned Medium from Human Uterine Cervical Stem Cells in an Ovarian Cancer Xenograft Mouse Model

    Cancer genomics & proteomics, Vol. 19, Núm. 5, pp. 570-575

  3. Thematic analysis of illness narratives as an example of an approach to better understand the lived experience of women diagnosed with breast cancer in Spain

    BMJ open, Vol. 12, Núm. 10, pp. e060935

2021

  1. Advanced nanomedicine and cancer: Challenges and opportunities in clinical translation

    International Journal of Pharmaceutics, Vol. 599

  2. Functional heterogeneity of mesenchymal stem cells from natural niches to culture conditions: implications for further clinical uses

    Cellular and Molecular Life Sciences, Vol. 78, Núm. 2, pp. 447-467

  3. Joint tumor bud–mmp/timp count at the invasive front improves the prognostic evaluation of invasive breast carcinoma

    Biomedicines, Vol. 9, Núm. 2, pp. 1-15

  4. Low birth weight trends in Organisation for Economic Co-operation and Development countries, 2000–2015: economic, health system and demographic conditionings

    BMC Pregnancy and Childbirth, Vol. 21, Núm. 1

2019

  1. Breast cancer tumor stroma: Cellular components, phenotypic heterogeneity, intercellular communication, prognostic implications and therapeutic opportunities

    Cancers, Vol. 11, Núm. 5, pp. 1-26

  2. Corrigendum: Antifungal activity of the human uterine cervical stem cells conditioned medium (hUCESC-CM) against candida albicans and other medically relevant species of candida (Frontiers in Microbiology (2018) 9 (2818) DOI: 10.3389/fmicb.2018.02818)

    Frontiers in Microbiology

  3. Mesenchymal stem cells in homeostasis and systemic diseases: Hypothesis, evidences, and therapeutic opportunities

    International Journal of Molecular Sciences, Vol. 20, Núm. 15

  4. Normalized second and fourth finger lengths in male and female partners and IVF cycle outcomes

    Reproductive BioMedicine Online, Vol. 38, Núm. 5, pp. 808-815

  5. Relationship between EGFR expression and subcellular localization with cancer development and clinical outcome

    Oncotarget, Vol. 10, Núm. 20, pp. 1918-1931

  6. “Ductal carcinoma in situ”: The curse of a name

    Revista de Senologia y Patologia Mamaria

2018

  1. Antifungal activity of the human uterine cervical stem cells conditioned medium (hUCESC-CM) against candida albicansand other medically relevant species of candida

    Frontiers in Microbiology, Vol. 9, Núm. NOV

  2. Mammographic screening: the beginning of the end?

    Revista de Senologia y Patologia Mamaria

  3. Non pregnant human uterus as source of mesenchymal stem cells

    Current Stem Cell Research and Therapy, Vol. 13, Núm. 6, pp. 423-431

2017

  1. A Prospective Randomized Trial of Postural Changes vs Passive Supine Lying during the Second Stage of Labor under Epidural Analgesia

    Medical sciences (Basel, Switzerland), Vol. 5, Núm. 1

  2. Mesenchymal stem cell secretome: Toward cell-free therapeutic strategies in regenerative medicine

    International Journal of Molecular Sciences, Vol. 18, Núm. 9